Barclays
BBNX icon

Barclays’s Beta Bionics BBNX Stock Holding History

Barclays’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.26M Buy
66,346
+51,410
+344% +$923K ﹤0.01% 2887
2026
Q2 		$234K Buy
14,936
+7,592
+103% +$90.3K ﹤0.01% 3614
2026
Q1 		$73.6K Sell
7,344
-53,320
-88% -$789K ﹤0.01% 4156
2025
Q4 		$1.85M Buy
60,664
+6,250
+11% +$167K ﹤0.01% 2993
2025
Q3 		$1.08M Buy
54,414
+31,734
+140% +$558K ﹤0.01% 3317
2025
Q2 		$330K Buy
22,680
+5,255
+30% +$74.4K ﹤0.01% 3994
2025
Q1 		$213K Buy
+17,425
New +$325K ﹤0.01% 4004

Other funds holding BBNX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Barclays's BBNX Position: Q3 2026 in Review

Barclays increased its Beta Bionics (BBNX) stake by 344% in Q3 2026, buying an estimated $923K and bringing the position to 66,346 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2887.

Barclays first reported a position in BBNX in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.85M in Q4 2025. 46 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Barclays held 66,346 shares of Beta Bionics worth $1.26M as of Q3 2026.
  • Barclays bought 51,410 Beta Bionics shares in Q3 2026, an estimated $923K.
  • Beta Bionics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2887 holding.
  • Barclays first reported a position in Beta Bionics in Q1 2025 and has held it in 7 quarters since.
  • Barclays's Beta Bionics position peaked at $1.85M in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.